The Quezon City government declared a dengue outbreak on Saturday after cases skyrocketed by 200 percent from Jan. 1 to Feb.

The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ...

Researchers identified three new all-oral drug regimens that include at least one of two new drugs for treatment of ...

Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...

If AV-1 shows promising results in this clinical trial, researchers may pursue further clinical evaluations of its safety and ...

New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study estimates. But experts urge caution.

Scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers with minimal side effects. In mouse tests, the new therapy completely eradicated ...

The crucial drugs can have unintended consequences. Innovative therapies could shield the microbiome from their effects.

Researchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at ...

Island Pharmaceuticals has completed subject dosing for the phase 2b therapeutic arm of its phase 2a/b PROTECT clinical trial ...

The trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.